Universe Pharmaceuticals Files 2024 Annual Report
Ticker: UPC · Form: 20-F · Filed: Apr 29, 2025 · CIK: 1809616
| Field | Detail |
|---|---|
| Company | Universe Pharmaceuticals INC (UPC) |
| Form Type | 20-F |
| Filed Date | Apr 29, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: annual-report, 20-f, pharmaceuticals
TL;DR
Universe Pharmaceuticals filed its 2024 20-F, check it for biz updates.
AI Summary
Universe Pharmaceuticals Inc. filed its annual report on Form 20-F for the fiscal year ended September 30, 2024. The company, incorporated in F4 and headquartered in Ji'an, Jiangxi, operates in the pharmaceutical preparations sector. This filing serves as an annual report, not a registration statement or transition report.
Why It Matters
This filing provides investors and the public with a comprehensive overview of Universe Pharmaceuticals' financial performance and business operations for the past fiscal year.
Risk Assessment
Risk Level: medium — As a foreign private issuer filing a 20-F, the company's reporting standards and regulatory oversight may differ from domestic US companies, introducing a layer of risk.
Key Numbers
- 20240930 — Fiscal Year End (The period covered by the annual report.)
- 20250429 — Filing Date (The date the 20-F was submitted to the SEC.)
Key Players & Entities
- Universe Pharmaceuticals INC (company) — Filer of the 20-F
- 0001213900-25-036798 (filing_id) — Accession number for the filing
- 20250429 (date) — Filing date
- 20240930 (date) — Fiscal year end date
- 001-40231 (company_file_number) — SEC file number for Universe Pharmaceuticals
- 265 JINGJIU AVENUE (address) — Street address of Universe Pharmaceuticals
- JI'AN, JIANGXI (location) — City and state of Universe Pharmaceuticals headquarters
FAQ
What is the primary purpose of this filing?
This filing is an annual report on Form 20-F for the fiscal year ended September 30, 2024, as indicated by the 'ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934' checkbox being selected.
What is the SEC file number for Universe Pharmaceuticals Inc.?
The SEC file number for Universe Pharmaceuticals Inc. is 001-40231.
Where is Universe Pharmaceuticals Inc. located?
Universe Pharmaceuticals Inc. is located at 265 JINGJIU AVENUE, JINGGANGSHAN ECON. AND TECH. DEV. ZONE, JI'AN, JIANGXI, F4, ZIP: 343100.
What industry does Universe Pharmaceuticals Inc. operate in?
Universe Pharmaceuticals Inc. operates in the 'PHARMACEUTICAL PREPARATIONS' industry, with Standard Industrial Classification code 2834.
When was this 20-F filing submitted?
This 20-F filing was submitted on April 29, 2025.
Filing Details
This Form 20-F (Form 20-F) was filed with the SEC on April 29, 2025 regarding Universe Pharmaceuticals INC (UPC).